3-[2-[(4aS,7aR)-3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl]-4-[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-N-methyl-benzamide

ID: ALA5220606

PubChem CID: 156560495

Max Phase: Preclinical

Molecular Formula: C27H32N6O3

Molecular Weight: 488.59

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCO[C@@H]5CCC[C@@H]54)nc3n2)c1

Standard InChI:  InChI=1S/C27H32N6O3/c1-17-16-35-13-11-32(17)25-20-9-10-21(18-5-3-6-19(15-18)26(34)28-2)29-24(20)30-27(31-25)33-12-14-36-23-8-4-7-22(23)33/h3,5-6,9-10,15,17,22-23H,4,7-8,11-14,16H2,1-2H3,(H,28,34)/t17-,22-,23+/m0/s1

Standard InChI Key:  YCXYINFZTDDUSW-PDIWNELESA-N

Molfile:  

 
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   -1.7207    0.6464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4424    0.2466    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4569   -0.5782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7498   -1.0033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0282   -0.6034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0136    0.2214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3229   -1.0267    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3989   -0.6269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4151    0.1937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2889    0.6227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1131   -1.0392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8275   -0.6270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5393   -1.0389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5393   -1.8638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8294   -2.2755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1131   -1.8675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2535   -0.6265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2535    0.1982    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9678   -1.0389    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6820   -0.6265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7207    1.4711    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4350    1.8835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4350    2.7082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7207    3.1206    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0064    2.7083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0064    1.8835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1492    1.4711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1711   -0.9906    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1711   -1.8154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8854   -2.2277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5997   -1.8153    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5997   -0.9906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8854   -0.5782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7140   -3.0343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5583   -2.3672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8938   -3.1206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4569   -1.4030    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6820   -2.4412    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  2  0
  1  6  1  0
  5  7  1  0
  8  7  2  0
  9  8  1  0
 10  9  2  0
  6 10  1  0
  8 11  1  0
 12 11  2  0
 13 12  1  0
 14 13  2  0
 15 14  1  0
 16 15  2  0
 11 16  1  0
 13 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
  1 21  1  0
 22 21  1  0
 23 22  1  0
 24 23  1  0
 25 24  1  0
 26 25  1  0
 21 26  1  0
 22 27  1  1
  3 28  1  0
 29 28  1  0
 30 29  1  0
 31 30  1  0
 32 31  1  0
 33 32  1  0
 28 33  1  0
 30 34  1  0
 29 35  1  0
 35 36  1  0
 36 34  1  0
 29 37  1  6
 30 38  1  6
M  END

Alternative Forms

  1. Parent:

    ALA5220606

    ---

Associated Targets(Human)

MTOR Tclin mTORC1 (330 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTOR Tclin mTORC2 (162 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 488.59Molecular Weight (Monoisotopic): 488.2536AlogP: 3.03#Rotatable Bonds: 4
Polar Surface Area: 92.71Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.00CX LogP: 4.08CX LogD: 4.08
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.60Np Likeness Score: -0.91

References

1. Oleksak P, Nepovimova E, Chrienova Z, Musilek K, Patocka J, Kuca K..  (2022)  Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021).,  238  [PMID:35688004] [10.1016/j.ejmech.2022.114498]

Source